bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride | 85081-14-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride
• 英文别名: 3,6-Ethano-Δ⁴-tetrahydro-phthalsaeure-anhydrid；4-oxatricyclo[5.2.2.02,6]undec-8-ene-3,5-dione
• CAS: 85081-14-7
• 化学式: C₁₀H₁₀O₃
• mdl: MFCD06796361
• 分子量: 178.188
• InChiKey: YIHKILSPWGDWPR-UHFFFAOYSA-N

物化性质

• 沸点：
  340.9±42.0 °C(Predicted)
• 密度：
  1.324±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride 在 碘 、 碳酸氢钠 作用下， 以 乙酸乙酯 为溶剂， 以3.5 g的产率得到endo-2-carboxy-4-oxo-5-oxa-exo-10-iodotricyclo<4.3.1.0^3,7>decane
  参考文献：
  名称：

  Alberts, Vincent; Brecknell, Douglas J.; Carman, Raymond M., Australian Journal of Chemistry, 1981, vol. 34, # 8, p. 1719 - 1727

  摘要：

  DOI：
• 作为产物：
  描述：

  4-O-cyclohex-2-en-1-yl 1-O-methyl (Z)-but-2-enedioate 以80%的产率得到
  参考文献：
  名称：

  SCHMITZ E.; HEUCK U.; PREUSCHHOF H., J. PRAKT. CHEM., 1979, 321, NO 3, 387-394

  摘要：

  DOI：

文献信息

• [EN] FUSED QUINOLINE DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE QUINOLINE FUSIONNÉE ET UTILISATION DE CELUI-CI
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005105802A1

  公开（公告）日：2005-11-10

  The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) wherein Rl is a hydrogen atom and the like; R2 is a hydrogen atom, a hydrocarbon group optionally having substituent(s) and the like; R3 is unsubstituted (i.e., absence), a hydrogen atom and the like; R4 and R5 are the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s), and the like; R6 is (cyclic group optionally having substituent(s)) -carbonyl, and the like; R7, R8, R9 and R10 are the same or different and each is a hydrogen atom, halogen and the like; or R7 and R8, R8 and R9, and R9 and R10 may form a ring together with the adjacent carbon atoms; n is an integer of 1 to 5; --- represents unsubstituted (i.e., absence) or a single bond; and --- represents a single bond or a double bond, or a salt thereof, and the like.

  本发明旨在提供一种具有神经激肽2（NK2）受体拮抗作用的喹啉衍生物，并涉及一种由式（I）表示的化合物，其中R1是氢原子等；R2是氢原子，可选地具有取代基的碳氢基团等；R3是未取代的（即缺失），氢原子等；R4和R5相同或不同，每个是氢原子，可选地具有取代基的碳氢基团等；R6是（环状基团，可选地具有取代基）-羰基等；R7、R8、R9和R10相同或不同，每个是氢原子，卤素等；或R7和R8、R8和R9、以及R9和R10可以与相邻的碳原子一起形成环；n是1到5的整数；---表示未取代的（即缺失）或单键；---表示单键或双键，或其盐等。
• [EN] NEW BICYCLIC THIOPHENYLAMIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS THIOPHÉNYLAMIDE BICYCLIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2013189841A1

  公开（公告）日：2013-12-27

  The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, A, E and n are as described herein, compositions including the compounds and use thereof as fatty-acid binding protein (FABP) 4/5 inhibitors in the treatment of e.g. type 2 diabetes, atherosclerosis or cancer.

  这项发明提供了具有一般式（I）的新化合物，其中R1、R2、R3、R4、R5、R6、R7、A、E和n如本文所述，包括这些化合物的组合物以及将其用作脂肪酸结合蛋白（FABP）4/5抑制剂，用于治疗例如2型糖尿病、动脉粥样硬化或癌症。
• RESIST COMPOSITION, PATTERN FORMING PROCESS, POLYMER, AND MONOMER
  申请人：SHIN-ETSU CHEMICAL CO., LTD.

  公开号：US20170184967A1

  公开（公告）日：2017-06-29

  A polymer comprising recurring units containing a specific lactone ring and having an alkyl group on γ-butyrolactone skeleton of fused ring lactone and an alkyl ester substituent group intervening between the lactone structure and the polymer backbone is provided. A resist composition comprising the polymer as base resin is improved in such properties as DOF margin and MEF and quite effective for precise micropatterning.

  提供一种聚合物，其中包含含有特定内酯环的重复单元，并且在融合环内酯的γ-丁内酯骨架上具有烷基基团，以及在内酯结构和聚合物主链之间具有烷基酯取代基团。以该聚合物为基础树脂的抗蚀组合物在DOF边缘和MEF等性能方面得到改善，并且非常有效用于精确微图案化。
• [EN] INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS DE LA GRIPPE, PROCÉDÉS D'APPLICATION ET UTILISATIONS ASSOCIÉES
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018041091A1

  公开（公告）日：2018-03-08

  The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the manufacture of medicaments for treating of influenza.

  该发明提供了一种新型类似物作为流感病毒复制抑制剂，以及其制备方法，含有这些化合物的药物组合物，以及这些化合物和药物组合物在制造治疗流感药物的药物中的用途。
• Process for producing optically active hemiesters
  申请人：——

  公开号：US20010023302A1

  公开（公告）日：2001-09-20

  There is disclosed a process for producing an optically active hemiester of formula (1): 1 wherein R 1 , R 2 and R 5 represent the same meanings as described below, which comprises reacting a cyclic acid anhydride of formula (2): 2 wherein R 1 and R 2 are different and independently represent a hydrogen atom, a halogen atom, an alkyl group optionally substituted with an alkoxy group or a halogen atom, and the like, with a hydroxy compound of formula (3): R 3 OH   (3) wherein R 3 represents an alkyl group optionally substituted with an alkoxy group, a phenoxy group, a dialkylamino group or a halogen atom and the like, in the presence of an asymmetric catalyst.

  揭示了一种生产式（1）的光学活性半酯的过程：其中R1，R2和R5代表如下所述的相同含义，包括将式（2）的环酸酐与式（3）的羟基化合物在不对称催化剂存在下反应，其中R1和R2分别代表氢原子、卤素原子、可能用烷氧基或卤素原子取代的烷基基团等，R3代表可能用烷氧基、苯氧基、二烷基胺基或卤素原子取代的烷基基团等。

表征谱图